Peter Riedell

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Xencor
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Fate Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech/Roche
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Cellectis
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Cargo Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tessa Therapeutics
    Date added:
    09/18/2024
    Date updated:
    09/18/2024

Pages

Return to Chicago Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice